Parkinson disease trials in Japan

4 of 9 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease

  Where

  Bunkyo-ku, Iruma-gun, Kanagawa, Tokushima, Tokyo

  Age

  18 years to 69 years

  People

  100 worldwide

  Run by

  AbbVie

  See details and how to joinNCT07227896
• No phaseTaking people
  A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications

  Where

  Akashi

  Age

  30 years to 99 years

  People

  60 worldwide

  Run by

  InSightec

  See details and how to joinNCT05539196
• No phaseEnrolling by invitation
  An Observational Study of Patients With Moderate Parkinson's Disease

  Where

  Shinjuku-ku, Tokyo

  Age

  50 years to 68 years

  People

  96 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT05779475
• No phaseTaking people
  Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases

  Where

  Gifu

  Age

  18 years and over

  People

  350 worldwide

  Run by

  Kliniken Beelitz GmbH

  See details and how to joinNCT04706234